Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Compound 4 is a promising treatment for hair loss with low toxicity.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Finasteride safely treats enlarged prostate and male-pattern baldness.

The compounds tested could potentially treat hair loss and alopecia.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

The compound 4c effectively inhibits the enzyme linked to hair loss.